ATON Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
9
- Stock Symbol
-
ALTAO
- Investments
-
3
ATON General Information
Description
Aton is a biopharmaceutical company that foresees a focused future of medicine. The company specializes in the main businesses: Inoviem Scienfic and B Cell Design. The company's services include pre-clinical and Clinical Services, Monoclonal Antibodies Production, Laboratory equipment Production, and Human Tissue Provision.
Contact Information
Website
www.aton-group.comCorporate Office
- 850 Boulevard Sébastien Brant
- 67400 Illkirch-Graffenstaden
- France
Corporate Office
- 850 Boulevard Sébastien Brant
- 67400 Illkirch-Graffenstaden
- France
ATON Stock Performance
As of 20-Nov-2026, ATON’s current market cap is $6.93M with 1.13B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.93M | 1.13B | 23.7M |
ATON Financials Summary
As of 30-Jun-2026, ATON has a trailing 12-month revenue of $700K.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 19,338 | 12,235 | 13,927 | 13,623 |
| Revenue | 700 | 746 | 664 | 662 |
| EBITDA | (327) | (117) | (691) | (775) |
| Net Income | (1,121) | (1,085) | (1,191) | (8,515) |
| Total Assets | 6,457 | 6,821 | 6,713 | 10,790 |
| Total Debt | 4,708 | 5,816 | 4,843 | 7,603 |
ATON Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ATON Patents
ATON Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020120644-A1 | New anti tau svqivykpv epitope single domain antibody | Inactive | 13-Dec-2018 | ||
| EP-3487506-A1 | Combinations of inecalcitol with an anti-cd38 agent and their uses for treating cancer | Inactive | 20-Jul-2016 | ||
| US-10478497-B2 | Combinations of inecalcitol with an anti-cd38 agent and their uses for treating cancer | Active | 20-Jul-2016 | ||
| US-20180021432-A1 | Combinations of inecalcitol with an anti-cd38 agent and their uses for treating cancer | Active | 20-Jul-2016 | ||
| WO-2018015498-A1 | Combinations of inecalcitol with an anti-cd38 agent and their uses for treating cancer | Inactive | 20-Jul-2016 | A61K39/39558 |
ATON Signals
ATON Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ATON Acquisitions (3)
ATON’s most recent deal was a Merger/Acquisition with Imaxio (Genomics Unit). The deal was made on 11-Oct-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Imaxio (Genomics Unit) | 11-Oct-2013 | Merger/Acquisition | Other Healthcare Services | ||
| Dualsystems Biotech (Y2H Activities) | 01-Jul-2013 | Merger/Acquisition | Other Healthcare Services | ||
| Semaia Pharmaceuticals | 29-Apr-2003 | Merger/Acquisition | Drug Discovery |
ATON ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
ATON FAQs
-
When was ATON founded?
ATON was founded in 1998.
-
Where is ATON headquartered?
ATON is headquartered in Illkirch-Graffenstaden, France.
-
What is the size of ATON?
ATON has 9 total employees.
-
What industry is ATON in?
ATON’s primary industry is Drug Discovery.
-
Is ATON a private or public company?
ATON is a Public company.
-
What is ATON’s stock symbol?
The ticker symbol for ATON is ALTAO.
-
What is the current market cap of ATON?
The current market capitalization of ATON is $6.93M.
-
What is ATON’s current revenue?
The trailing twelve month revenue for ATON is $700K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process